IMAX Corporation (IMAX) PT Raised to $19 at Benchmark

December 15, 2020 8:27 AM EST
Get Alerts IMAX Hot Sheet
Price: $15.60 -2.56%

Rating Summary:
    10 Buy, 7 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 22 | Down: 13 | New: 31
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Benchmark analyst Mike Hickey raised the price target on IMAX Corporation (NYSE: IMAX) to $19.00 while maintaining a Buy rating.

The analyst commented, "We have raised our PT to $19 and reiterate Buy rating on IMAX Corp. We suspect IMAX offers a bounce back trade of nearly 50% if the share price were to return to pre-pandemic levels. The virus influence has forced the shut down of theaters, delay of planned movies releases and created volatility around traditional film windows including PVOD and streaming. We believe the recent distribution of vaccines will mitigate the impact of the virus influence. We anticipate the vast majority of theaters will re-open in FY21, blockbuster films will in-fact release, and movie goers will return to theaters as we have witnessed in other key cinema markets including China and Japan. We believe IMAX domestic screen count in the US will have limited impact from potential exhibitor bankruptcy."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change